Transient Hyperphosphatasemia Due to Pomegranate Juice
نویسندگان
چکیده
منابع مشابه
Transient hyperphosphatasemia in children.
Transient Hyperphosphatasemia (TH) is a benign condition in which serum alkaline phosphatase (ALP) is transiently elevated in the absence of other systemic diseases. It mainly occurs in infants and children and very rarely seen in adults. The differential diagnosis may include liver, bone, kidney, intestinal, placental and blood diseases as well as other serious conditions as well as bone fract...
متن کاملbENIgN trANSIENt hyPErPhoSPhAtASEmIA of ChIlDhooD
Objective: To report a case series of benign transient hyperphosphatasemia of infancy (BTHI). Description (Case report): A series of four girls with BTHI is described. The age range was 11-45 months (median: 13 months). At diagnosis, the serum alkaline phosphatase was 1.16.1 times (median: 1.36) above the reference values. Return to normal values occurred between 7-11 months (median: 9 months)....
متن کاملPomegranate juice: a heart-healthy fruit juice.
Pomegranate juice is a polyphenol-rich fruit juice with high antioxidant capacity. In limited studies in human and murine models, pomegranate juice has been shown to exert significant antiatherogenic, antioxidant, antihypertensive, and anti-inflammatory effects. Pomegranate juice significantly reduced atherosclerotic lesion areas in immune-deficient mice and intima media thickness in cardiac pa...
متن کاملNormal Bone Turnover in Transient Hyperphosphatasemia
Transient hyperphosphatasemia of infancy and early childhood (THI) is characterized by a temporary isolated elevation of serum alkaline phosphatase activity (ALP), predominantly its bone or liver isoform, in either sick or healthy children under 5 years of age. Return to normal ALP levels usually occurs within four months. Spontaneous rise of ALP might concern the physician, especially when tre...
متن کاملPomegranate Juice Intake and Cardiovascular Health
The public health burden of cardiovascular diseases (CVDs) is substantial. According to the World Health Organization report “The Global Burden of Disease” 2013 Update, heart diseases are expected to take the second place in the rank order of disease and injury burden by the year 2030 [1]. More than 50% reduction of CVD mortality is attributable to favourable changes in risk factors, while 43% ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cureus
سال: 2021
ISSN: 2168-8184
DOI: 10.7759/cureus.14779